The drug treatment of duodenal ulcer: physiological considerations in the choice of therapy
- PMID: 2875708
- DOI: 10.1111/j.1445-5994.1986.tb01176.x
The drug treatment of duodenal ulcer: physiological considerations in the choice of therapy
Similar articles
-
[Duodenal peptic ulcer. Medical therapy].Rev Gastroenterol Mex. 1984 Jul-Sep;49(3):179-84. Rev Gastroenterol Mex. 1984. PMID: 6151237 Spanish. No abstract available.
-
Sucralfate, bismuth compounds, substituted benzimidazoles, trimipramine and pirenzepine in the short- and long-term treatment of duodenal ulcer.Clin Gastroenterol. 1984 May;13(2):543-68. Clin Gastroenterol. 1984. PMID: 6378446 Review. No abstract available.
-
Pharmacologic options for the control of peptic ulcer disease.Adv Intern Med. 1984;30:425-47. Adv Intern Med. 1984. PMID: 6152108 Review. No abstract available.
-
Stress ulcers--prevention of gastrointestinal bleeding in critical care units.Med J Aust. 1985 Feb 4;142 Spec No:S17-20. doi: 10.5694/j.1326-5377.1985.tb128344.x. Med J Aust. 1985. PMID: 2869398 No abstract available.
-
[Conservative treatment of gastric ulcer].Med Klin. 1980 Aug 29;75(18):638-44. Med Klin. 1980. PMID: 6106882 Review. German. No abstract available.
Cited by
-
Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.Drugs. 1988 Aug;36(2):132-57. doi: 10.2165/00003495-198836020-00002. Drugs. 1988. PMID: 3053124 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources